text
stringlengths
81
4.38k
<s>[INST] Provide exclusion criteria for trial id: NCT01299623 [/INST] Non-African American Male Under 35 or over 70 years of age Personal history of cancer Not a resident of Philadelphia Metropolitan Area </s>
<s>[INST] Provide description for trial id: NCT01299623 [/INST] We will develop and evaluate a community-based approach for disseminating comparative effective reviews (CERs) about breast cancer prevention to African American women. The specific aims of our research, as shown below, will target this population because...
<s>[INST] Provide title for trial id: NCT01299623 [/INST] Breast Cancer Prevention Education </s>
<s>[INST] Provide the recruitment status for trial id: NCT01299623 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT01299623 [/INST] Breast Cancer Prevention </s>
<s>Trial Id: Ethnic Predisposition, Risk Factors & Breast Cancer Presentation. Recruitment Status: Completed Trail description: Breast cancer, a leading cause of mortality among females, has been the center of research for many decades. Work is in progress to further advance the research worldwide and in our region. Th...
<s>[INST] Provide inclusion criteria for trial id: NCT05458570 [/INST] female sex, age ≥ 20 years, patients with availability of complete clinical details, biopsy proven breast cancer, no previous history of breast cancer treatment from other centers, males, all regional ethnicities(residents of Karachi, Sindh) and al...
<s>[INST] Provide exclusion criteria for trial id: NCT05458570 [/INST] previously treated breast cancer patients, female ≤19 years, male/transgender, females coming for treatment for other provinces/foreigners. </s>
<s>[INST] Provide description for trial id: NCT05458570 [/INST] Breast cancer, a leading cause of mortality among females, has been the center of research for many decades. Work is in progress to further advance the research worldwide and in our region. This study is conducted to look into regional ethical predilectio...
<s>[INST] Provide title for trial id: NCT05458570 [/INST] Ethnic Predisposition, Risk Factors & Breast Cancer Presentation. </s>
<s>[INST] Provide the recruitment status for trial id: NCT05458570 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT05458570 [/INST] Breast Cancer </s>
<s>Trial Id: Breast Cancer Survivors: Main Physical and Psychosocial Problems After Completion of Treatment Recruitment Status: Unknown status Trail description: Breast cancer directly affects women physically, psychologically and socially in the process of diagnosis, treatment and post-treatment. Despite the improveme...
<s>[INST] Provide inclusion criteria for trial id: NCT04834570 [/INST] Breast cancer Adult women (age ≥ 20 years old and less than 60 years old) Patient who has been treated by surgery, with or without adjuvant chemotherapy Clinical Stages I, II and III Patients considered cured, without history of recurrences Patient...
<s>[INST] Provide exclusion criteria for trial id: NCT04834570 [/INST] Initial diagnosis of another type of cancer, other than breast cancer Bilateral breast cancer Patient unable to fill out the QoL questionnaire Patient with disease recurrence Patient with metastatic breast cancer </s>
<s>[INST] Provide description for trial id: NCT04834570 [/INST] Breast cancer directly affects women physically, psychologically and socially in the process of diagnosis, treatment and post-treatment. Despite the improvement in conventional breast cancer treatments that led to longer disease-free survival, many patien...
<s>[INST] Provide title for trial id: NCT04834570 [/INST] Breast Cancer Survivors: Main Physical and Psychosocial Problems After Completion of Treatment </s>
<s>[INST] Provide the recruitment status for trial id: NCT04834570 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT04834570 [/INST] Breast Cancer </s>
<s>Trial Id: No Axillary Surgery for Early Breast Cancer. Recruitment Status: Completed Trail description: After breast cancer (BC) screening was introduced for all Swedish women in 1989-90 the number of early invasive BC, clin N0 rose dramatically. For these BC it was known that only 10 % or less was N+ after axillary...
<s>[INST] Provide inclusion criteria for trial id: NCT03669705 [/INST] Invasive breast cancer, unifocal T=max 10mm Clinical node negative and clinical M0 Histological grade 1 or 2 Both screening / clinical detected accepted Radical operation = free margins in breast specimen Partial mastectomy and mastectomy accepted ...
<s>[INST] Provide exclusion criteria for trial id: NCT03669705 [/INST] Previous breast cancer diagnosis, including carcinoma in situ Previous ipsilateral axillary dissection Non radical operation = no free margins Multifocal cancer Previous treatment for other cancer. Unable to understand information (informed consent...
<s>[INST] Provide description for trial id: NCT03669705 [/INST] After breast cancer (BC) screening was introduced for all Swedish women in 1989-90 the number of early invasive BC, clin N0 rose dramatically. For these BC it was known that only 10 % or less was N+ after axillary dissection and the morbidity for axillary...
<s>[INST] Provide title for trial id: NCT03669705 [/INST] No Axillary Surgery for Early Breast Cancer. </s>
<s>[INST] Provide the recruitment status for trial id: NCT03669705 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT03669705 [/INST] Breast Cancer Invasive </s>
<s>Trial Id: Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy Recruitment Status: Recruiting Trail description: This multicenter clinical study aims to build an intelligent and accurate diagnosis and dynamic prediction and early warning model of cardiotoxicity due to...
<s>[INST] Provide inclusion criteria for trial id: NCT06282796 [/INST] Age ≥18 years Histologically or cytopathological confirmed stage I-III HER2+ breast cancer, scheduled to receive consecutive anthracycline chemotherapy or subsequent sequential trastuzumab targeted therapy LVEF≥53% before chemotherapy </s>
<s>[INST] Provide exclusion criteria for trial id: NCT06282796 [/INST] life expectancy ≤12 months Participating in other ongoing oncology clinical trials Prior treatment with anthracyclines or chest radiation therapy Pregnant or lactating women Ultrasound images of the heart are of very poor quality </s>
<s>[INST] Provide description for trial id: NCT06282796 [/INST] This multicenter clinical study aims to build an intelligent and accurate diagnosis and dynamic prediction and early warning model of cardiotoxicity due to anthracycline-based breast cancer chemotherapy, clarify the value of the early warning model in gui...
<s>[INST] Provide title for trial id: NCT06282796 [/INST] Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy </s>
<s>[INST] Provide the recruitment status for trial id: NCT06282796 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT06282796 [/INST] Breast Cancer </s>
<s>Trial Id: Increasing African Immigrant Women's Participation in Breast Cancer Screening Recruitment Status: Completed Trail description: New York City (NYC) is home to a large and diverse immigrant population. Many of these groups face significant barriers to preventive health care, including lack of insurance, poor...
<s>[INST] Provide inclusion criteria for trial id: NCT04450264 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04450264 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT04450264 [/INST] New York City (NYC) is home to a large and diverse immigrant population. Many of these groups face significant barriers to preventive health care, including lack of insurance, poor health care access and language difficulties. Most African immigrant women...
<s>[INST] Provide title for trial id: NCT04450264 [/INST] Increasing African Immigrant Women's Participation in Breast Cancer Screening </s>
<s>[INST] Provide the recruitment status for trial id: NCT04450264 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT04450264 [/INST] Breast Cancer </s>
<s>Trial Id: A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers Recruitment Status: Completed Trail description: In this study, the investigators will enroll women with palpable cancers to assess the accuracy of the Breast Cancer Locator (BCL) and the concomitant procedu...
<s>[INST] Provide inclusion criteria for trial id: NCT02550210 [/INST] Age greater than or equal to 18 years Histologic diagnosis of palpable invasive breast cancer or ductal carcinoma in situ Patient desire to undergo breast surgery Ability to voluntarily provide informed consent to participate prior to any study-rel...
<s>[INST] Provide exclusion criteria for trial id: NCT02550210 [/INST] Absolute contraindication to MRI, including presence of implanted electrical device (pacemaker or neurostimulator), aneurysm clip, or metallic foreign body in or near eyes Severe claustrophobia Contraindication to use of gadolinium-based intravenou...
<s>[INST] Provide description for trial id: NCT02550210 [/INST] In this study, the investigators will enroll women with palpable cancers to assess the accuracy of the Breast Cancer Locator (BCL) and the concomitant procedure as a vehicle to optimize and validate the approach in such surgical cases. This approach of ad...
<s>[INST] Provide title for trial id: NCT02550210 [/INST] A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers </s>
<s>[INST] Provide the recruitment status for trial id: NCT02550210 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT02550210 [/INST] Breast Cancer </s>
<s>Trial Id: The HIFUB Study (HIFU in Breast Cancer) Recruitment Status: Unknown status Trail description: High Intensity Focused Ultrasound (HIFU) is a new method of treating solid tumours by thermally ablating them. It has been used in a number of different types of cancers but there is little information on its use ...
<s>[INST] Provide inclusion criteria for trial id: NCT05350059 [/INST] Participant is willing and able to give informed consent for participation in the trial. Female, aged 18 years or above. Histologically confirmed breast cancer (invasive ductal cancer) by core biopsy, which is suitable for surgical resection. Parti...
<s>[INST] Provide exclusion criteria for trial id: NCT05350059 [/INST] Female participant who is pregnant. Significant renal or hepatic impairment. An inadequate biopsy determination of oestrogen, progesterone, HER2 receptor status on pre-operative biopsy. Unable to visualize lesion or tumour boundaries clearly on ult...
<s>[INST] Provide description for trial id: NCT05350059 [/INST] High Intensity Focused Ultrasound (HIFU) is a new method of treating solid tumours by thermally ablating them. It has been used in a number of different types of cancers but there is little information on its use in invasive breast cancer (IBC). The inves...
<s>[INST] Provide title for trial id: NCT05350059 [/INST] The HIFUB Study (HIFU in Breast Cancer) </s>
<s>[INST] Provide the recruitment status for trial id: NCT05350059 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT05350059 [/INST] Breast Cancer </s>
<s>Trial Id: A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers Recruitment Status: Completed Trail description: The project objective is to determine whether the Breast Cancer Locator (BCL) can safely and effectively localize breast cancers in patien...
<s>[INST] Provide inclusion criteria for trial id: NCT03573661 [/INST] Age > 18 years. Histologic diagnosis of palpable invasive breast cancer or ductal carcinoma in situ. Patient desire to undergo breast surgery (lumpectomy or non-skin sparing mastectomy). Ability to voluntarily provide informed consent to participat...
<s>[INST] Provide exclusion criteria for trial id: NCT03573661 [/INST] Absolute contraindication to MRI, including presence of implanted electrical device (pacemaker or neurostimulator), aneurysm clip, or metallic foreign body in or near eyes. Severe claustrophobia. Contraindication to use of gadolinium-based intraven...
<s>[INST] Provide description for trial id: NCT03573661 [/INST] The project objective is to determine whether the Breast Cancer Locator (BCL) can safely and effectively localize breast cancers in patients treated at locations distant from the site of BCL manufacture. This information will be transmitted to CairnSurgic...
<s>[INST] Provide title for trial id: NCT03573661 [/INST] A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers </s>
<s>[INST] Provide the recruitment status for trial id: NCT03573661 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT03573661 [/INST] Palpable Breast Cancer </s>
<s>Trial Id: Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast Cancer Recruitment Status: Not yet recruiting Trail description: Measurement of serum levels of Retinoic acid induced 14 (RAI14) and Metastasis associated cancer colon -1 (MACC-1) as biomarkers for d...
<s>[INST] Provide inclusion criteria for trial id: NCT06097546 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT06097546 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT06097546 [/INST] Measurement of serum levels of Retinoic acid induced 14 (RAI14) and Metastasis associated cancer colon -1 (MACC-1) as biomarkers for diagnosis of breast cancer. Study their relationship to disease stages and clinicopathological features of BC. Compare the...
<s>[INST] Provide title for trial id: NCT06097546 [/INST] Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT06097546 [/INST] Not yet recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT06097546 [/INST] Breast Cancer </s>
<s>Trial Id: Whole Genome Sequencing in Breast Cancer Recruitment Status: Recruiting Trail description: This study aims to conduct whole genome sequencing in breast cancer patients to elucidate individual genetic characteristics and their correlation with breast cancer subtypes. The primary objective is to establish ne...
<s>[INST] Provide inclusion criteria for trial id: NCT06334471 [/INST] Patients who have consented to both the patient consent form and the consent for the use of human-derived materials. Patients who are aged 19 years or older at the time of signing the consent form. Patients capable of providing written consent to p...
<s>[INST] Provide exclusion criteria for trial id: NCT06334471 [/INST] Patients who do not understand or refuse to consent in writing. Patients for whom obtaining sufficient samples is challenging. Patients who refuse genetic testing. [Retrospective study] Inclusion Criteria: Patients histologically confirmed with ...
<s>[INST] Provide description for trial id: NCT06334471 [/INST] This study aims to conduct whole genome sequencing in breast cancer patients to elucidate individual genetic characteristics and their correlation with breast cancer subtypes. The primary objective is to establish new treatment guidelines aligned with the...
<s>[INST] Provide title for trial id: NCT06334471 [/INST] Whole Genome Sequencing in Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT06334471 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT06334471 [/INST] Breast Cancer </s>
<s>Trial Id: Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer Recruitment Status: Completed Trail description: Objective: To evaluate the impact of chemotherapy on periodontal conditions, hematology, and salivary flow in patients with breast cancer and gingivitis, after basic periodontal therap...
<s>[INST] Provide inclusion criteria for trial id: NCT06212908 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT06212908 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT06212908 [/INST] Objective: To evaluate the impact of chemotherapy on periodontal conditions, hematology, and salivary flow in patients with breast cancer and gingivitis, after basic periodontal therapy (BPT). Methods: They were divided into patients with breast cancer a...
<s>[INST] Provide title for trial id: NCT06212908 [/INST] Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT06212908 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT06212908 [/INST] Breast Cancer, Gingivitis, Periodontal </s>
<s>Trial Id: Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology Recruitment Status: Completed Trail description: The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the OSNA Breast Cancer System by comparing its perfo...
<s>[INST] Provide inclusion criteria for trial id: NCT01368744 [/INST] Male or female; 18 years of age or older; Diagnosed pre-surgically with T1 or T2 breast cancer without clinical evidence of axillary lymph node involvement and scheduled for surgery including sentinel lymph node dissection; Subjects (or the subject...
<s>[INST] Provide exclusion criteria for trial id: NCT01368744 [/INST] Subjects diagnosed pre-surgically with large or locally advanced (T3 & T4) breast cancer; Pregnant subjects, confirmed by interview with either subject or treating physician; Subjects diagnosed with inflammatory breast cancer; Subjects diagnosed wi...
<s>[INST] Provide description for trial id: NCT01368744 [/INST] The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the OSNA Breast Cancer System by comparing its performance to an extensive intraoperative frozen section protocol for Sentinel Lymph Nodes re...
<s>[INST] Provide title for trial id: NCT01368744 [/INST] Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology </s>
<s>[INST] Provide the recruitment status for trial id: NCT01368744 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT01368744 [/INST] Breast Neoplasms, Breast Diseases </s>
<s>Trial Id: Breast Cancer With Over-expression of erbB2-BRAINSTORM Recruitment Status: Completed Trail description: This retrospective cohort study aims to improve our understanding of the current paradigm for treatment of brain metastases in erbB2+ breast cancer patients in the Asia Pacific region. We aim to identify...
<s>[INST] Provide inclusion criteria for trial id: NCT01064349 [/INST] Female patients diagnosed with erbB2+ breast cancer. ErbB2 positivity will be as determined by respective institutional standards, and will be based on medical history only. Brain metastasis diagnosis made between January 2006 - December 2008. </s>
<s>[INST] Provide exclusion criteria for trial id: NCT01064349 [/INST] Women who have another primary cancer diagnosed between the time of breast cancer diagnosis and brain metastasis.. Patient has leptomeningeal metastases only without parenchymal brain involvement (since this pattern of the disease requires a differ...
<s>[INST] Provide description for trial id: NCT01064349 [/INST] This retrospective cohort study aims to improve our understanding of the current paradigm for treatment of brain metastases in erbB2+ breast cancer patients in the Asia Pacific region. We aim to identify approximately 300 erbB2+ breast cancer patients wit...
<s>[INST] Provide title for trial id: NCT01064349 [/INST] Breast Cancer With Over-expression of erbB2-BRAINSTORM </s>
<s>[INST] Provide the recruitment status for trial id: NCT01064349 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT01064349 [/INST] Cancer </s>
<s>Trial Id: RCT Comparing 2 Radiotherapy HypoFractionation Schedules In Breast Cancer Patients Recruitment Status: Unknown status Trail description: This is a prospective randomized Phase III trial to assess efficiency of two post mastectomy hypofractionation schedules (40 Gy /15 fx / 3 weeks, 5 days per week VS 28.5 ...
<s>[INST] Provide inclusion criteria for trial id: NCT04550910 [/INST] Invasive carcinoma of the breast. Complete microscopic excision of primary tumour and axillary dissection or SLNB . Females with locally advanced breast cancer ( T3/T4 or N + or both ) who are candidate for neoadjvant chemotherapy regardless pathol...
<s>[INST] Provide exclusion criteria for trial id: NCT04550910 [/INST] Patients do not match with inclusion criteria. Collagen vascular disease, specifically systemic lupus, or scleroderma. Pregnancy or lactation at the time of radiotherapy. </s>
<s>[INST] Provide description for trial id: NCT04550910 [/INST] This is a prospective randomized Phase III trial to assess efficiency of two post mastectomy hypofractionation schedules (40 Gy /15 fx / 3 weeks, 5 days per week VS 28.5 Gy delivered in 5 once-weekly fractions of 5.7 Gy each week) as adjuvant radiotherapy...